SCHEMBL23154589

SCHEMBL23154589

Brc1cc(Br)c(-c2ccc(-n3c4ccccc4c4ccccc43)cc2)cc1-c1ccc(-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ ATM Q13315 1/20 0.52
▸ HDAC4 P56524 1/20 0.42
▸ PTPN1 P18031 2/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ GPR3 P46089 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ EDNRA P25101 2/20 0.32
▸ EDNRB P24530 1/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ AKR1C4 P17516 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21580226 0.92 L3MBTL1 (0.52) L3MBTL1KDM4EATMHDAC4PTPN1
SCHEMBL2818191 0.84 L3MBTL1 (0.53) L3MBTL1KDM4EATMHDAC4PTPN1
SCHEMBL31321571 0.84 L3MBTL1 (0.53) L3MBTL1KDM4EATMHDAC4PTPN1
SCHEMBL14429664 0.84 L3MBTL1 (0.63) L3MBTL1KDM4EATMHDAC4PTPN1
SCHEMBL21943769 0.84 L3MBTL1 (0.63) L3MBTL1KDM4EATMHDAC4PTPN1
SCHEMBL14429702 0.84 L3MBTL1 (0.63) L3MBTL1KDM4EATMHDAC4PTPN1
SCHEMBL16202923 0.83 L3MBTL1 (0.53) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17742573 0.83 L3MBTL1 (0.52) L3MBTL1KDM4EATMHDAC4PTPN1
SCHEMBL16202928 0.82 L3MBTL1 (0.56) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL3474146 0.81 L3MBTL1 (0.50) L3MBTL1KDM4EATMHDAC4PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11758809-B2 Compound, display panel, and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-09-12 — — US disclosed
US-11758809-B2 Compound, display panel, and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-09-12 — — US disclosed
US-20210098712-A1 COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11758809-B2 Compound, display panel, and display apparatus C1S, C3AR1, DRD3 L3MBTL1 3173/4885KDM4E 4098/4885ATM 3265/4885
US-20210098712-A1 COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS C1S, C3AR1, DRD3 L3MBTL1 3173/4885KDM4E 4098/4885ATM 3265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback